经尿道2μm激光前列腺汽化切除术治疗良性前列腺增生临床观察

Clinical Observation of 2μm Transurethral Continuous Wave Laser Vaporization in Treatment of Benign Prostatic Hyperplasia

目的探讨经尿道2μm激光前列腺汽化切除术治疗良性前列腺增生(benign prostatic hyperplasia,BPH)的疗效和安全性。方法 2011年3月—2012年3月对BPH 110例应用经尿道2μm激光前列腺汽化切除术治疗,观察临床效果及并发症发生情况。结果本组手术均获成功。手术平均时间(66.33±19.66)min,术中平均出血量(67.27±28.91)ml,术后留置尿管时间(5.73±0.81)d,平均住院时间(17.62±4.55)d。IPSS评分和最大尿流率得到改善,且未发生并发症。结论应用经尿道2μm激光前列腺汽化切除术治疗良性BPH具有出血少、围术期安全性高、并发症少等优点,而且操作安全简便,是较为理想的微创性手术治疗方法。

Objective To explore the safety and efficacy of RevoLix 2 p.m transurethral continuous wave laser vaporization in treatment of benign prostatic hyperplasia （BPH）. Methods The clinical efficacy and complications of 110 patients with BPH during March 2011 and March 2012 treated with 2 μm transurethral continuous wave laser vapori- zation were observed. Results The 2 μm continuous wave laser vaporization were successfully performed for all patients. The mean operative time, intraoperative average blood loss, postoperation indwelling catheterization time and average hos- pital days was （66.33±19.66）min, （67.27±28.91）ml, （5.73±0.81）d and （17.62±4.55）d. IPSS scores and maximal urinary flow rate were improved without any complications. Conclusion The 2μm transurethral continuous wave laser may be a superior micro-invasive surgery for patients with BPH, which involves little blood loss, high safety, con- venient operation and less complications.